BridgeMD
New treatment option for Myelosuppression
Official title Trilaciclib Prevents Myelosuppression With Chemoradiotherapy
ClinicalTrials.gov ID: NCT06490081
What this study is testing
What is Trilaciclib?
Trilaciclib is an investigational medicine, being studied as a potential treatment for myelosuppression.
Also referred to as Trilaciclib combined with concurrent chemoradiotherapy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To evaluate the protective effect of Trilaciclib on myelosuppression in patients with limited-stage small cell lung cancer associated with concurrent chemoradiotherapy and discuss the effect of gut microbiota changes on myelosuppression
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- The histopathology is limited-stage small cell lung cancer.
- ECOG score 0-2.
- Good organ function (no blood transfusions, no hematopoietic stimulating factors, no transfusions of albumin or blood products within 14 days prior...
- It is suitable for patients treated with Trilaciclib combined with etoposide plus cisplatin or carboplatin.
- Understand and can sign informed consent
You likely can't join if
- Brain metastases with clinical symptoms require local radiotherapy or hormone therapy.
- Active infections require systemic treatment.
- people with active, known or suspected autoimmune disease or history of autoimmune disease.
- Combined with other tumors.
- The current or previous presence of a clinically significant and medically unstable condition, which in the investigator's professional judgment may...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.